Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Apr;7(4):483–485. doi: 10.1128/aac.7.4.483

In Vitro Evaluation of a New Quinolone Antibacterial

Gregory Stilwell *, King Holmes *, Marvin Turck *
PMCID: PMC429166  PMID: 1147584

Abstract

The activity of R-802, a quinolone antibacterial agent, was studied in vitro and found to be active against Enterobacteriaceae; less than 4 μg of drug per ml was required to inhibit most isolates. The majority of Pseudomonas aeruginosa grew in a concentration of 256 μg of R-802 per ml when studied in broth against an inoculum of 108 organisms per ml.

Full text

PDF
483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas E., Clark H., Silverblatt F., Turck M. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann Intern Med. 1969 Apr;70(4):713–721. doi: 10.7326/0003-4819-70-4-713. [DOI] [PubMed] [Google Scholar]
  2. Ronald A. R., Turck M., Petersdorf R. G. A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med. 1966 Nov 17;275(20):1081–1089. doi: 10.1056/NEJM196611172752001. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES